Gastrointestinal Malignancies in 2019
and Beyond

The latest translational and therapeutic developments in GI cancer pathogenesis and treatment, and implications on individualized clinical decision-making. How will emerging research affect ongoing clinical trials, development of new compounds, and future treatment paradigms?

Howard Hochster, MD, FACP, Aptitude Health Scientific Leader

Faculty Chair

Howard Hochster, MD, FACP

Rutgers Cancer Institute, New Brunswick, NJ, USA

Look Inside This Report

Download a sample of this report and start discovering the insights

Topics Covered

    • Metastatic Colorectal Cancer – Recent Insights and Future Approaches
    • Immune and Targeted Therapies
    • Chemotherapy and Radiation
    • Gastroesophageal Cancers
    • Hepatocellular and Biliary Tract Cancers
    • Biology-Guided Treatment of Locally Advanced/Metastatic Pancreatic Cancer
    • Strategic Recommendations

Faculty Members

Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center
Hamburg, Germany

Daniel Catenacci, MD
University of Chicago
Chicago, IL, USA

Michel Ducreux, MD, PhD
Institut Gustave Roussy
Villejuif, France

Axel Grothey, MD
West Cancer Center
Germantown, TN, USA

Scott Kopetz, MD, PhD
MD Anderson Cancer Center
Houston, TX, USA

Fotios Loupakis, MD, PhD
Veneto Institute of Oncology
Padua, Italy

Philip A. Philip, MD, PhD
Barbara Ann Karmanos Cancer Institute
Detroit, MI, USA

Explore Available and Upcoming Insight Reports

View Reports